Viemed Healthcare Inc. (VMD)
NASDAQ: VMD
· Real-Time Price · USD
6.65
0.08 (1.22%)
At close: May 30, 2025, 3:59 PM
6.65
0.00%
After-hours: May 30, 2025, 04:04 PM EDT
Viemed Healthcare Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Equipment Sales Revenue | 30.9M | 25.77M | 13.93M | 8.77M | 7.36M | 4.39M |
| Equipment Sales Revenue Growth | +19.89% | +85.04% | +58.89% | +19.14% | +67.39% | n/a |
| Service Revenue | 20.13M | 10.66M | 8.47M | 2.05M | 1.4M | 1.42M |
| Service Revenue Growth | +88.78% | +25.90% | +313.83% | +46.32% | -1.13% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 28.43M | 29.73M | 28.38M | 27.9M | 26.25M | 26.08M | 25.11M | 22.03M | 21.15M | 18.49M | 18.99M | 18.81M | 17.08M | 15.54M | 14.56M | 14.12M | 15.82M | 13.57M | 14.78M | 17.62M | 11.73M | 11.08M | 14.35M | 14.28M | 10.24M | 8.74M | 8.46M | 7.43M | 6.32M | 8.31M | 3.96M | 4.61M | 3.37M | 839K | 5.46M |
| Selling, General, and Administrative Revenue Growth | -4.40% | +4.75% | +1.72% | +6.31% | +0.64% | +3.87% | +13.95% | +4.16% | +14.41% | -2.62% | +0.95% | +10.10% | +9.88% | +6.75% | +3.13% | -10.72% | +16.51% | -8.18% | -16.11% | +50.27% | +5.83% | -22.75% | +0.47% | +39.41% | +17.16% | +3.36% | +13.82% | +17.62% | -23.99% | +110.11% | -14.21% | +36.91% | +301.43% | -84.62% | n/a |
| Research and Development Revenue | 797K | 803K | 757K | 758K | 750K | 668.99K | 593K | 758K | 780K | 722K | 670K | 672K | 632K | 612K | 576K | 583K | 339K | 395K | 243K | 271K | 174K | 203K | 208K | 203K | 234K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | -0.75% | +6.08% | -0.13% | +1.07% | +12.11% | +12.81% | -21.77% | -2.82% | +8.03% | +7.76% | -0.30% | +6.33% | +3.27% | +6.25% | -1.20% | +71.98% | -14.18% | +62.55% | -10.33% | +55.75% | -14.29% | -2.40% | +2.46% | -13.25% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |